Impact of Reimbursement for Biomarker Testing on Clinical PracticeVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”
Jennifer Malin discusses the aspects of value and how they are realized in personalized medicine
Dr Wainberg and Dr Gerson discuss the ongoing debate about whether clinicians should treat the surface or the internal structure of cancer stem cells.